Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that Professor Mike Sathekge, MBChB, M. Med (Nuclear Medicine), PhD Professor […]
SMi’s 2ndannual Injectable Drug Delivery Conference will take place at the Copthorne Tara Hotel, Kensington, London, on the 15th – 16th May 2019. Here is a snapshot of key topics and issues within Injectable Drug […]
Merck, known as MSD outside the United States and Canada, today announced topline findings from the final analysis of the pivotal Phase 3 KEYNOTE-062 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy and in combination […]
British drugmaker GlaxoSmithKline (GSK) is set to invest $100m to expand long-term vaccine manufacturing capabilities at its Hamilton facility in Montana, US. The investment will help GSK to expand the production capacity of major components […]
Biotheque Wallonie Bruxelles to lead a workshop at the 9th Annual Biobanking Conference SMi Group are delighted to have the industry expert Laurent Dolle, Managing Director, Biotheque Wallonie Bruxelles (BWB) to lead a pre-conference workshop […]